Mar 26, 2010, 05.39 PM IST

Surya Pharma has target of Rs 188: Gujral

Surya Pharmaceutical with target price of Rs 188, says Technical Analyst, Ashwani Gujral.

Share Share on Tumblr
Share  .  Email  .  Print  .  A+
Surya Pharma has target of Rs 188: Gujral
Surya Pharmaceutical with target price of Rs 188, says Technical Analyst, Ashwani Gujral .


Gujral told CNBC-TV18, "Before yesterday surprisingly Surya Pharma was moving sideways in a range of about 135 to 175. Yesterday was the first day it made an 8.5% kind of move with very high volume, so this move could really continue till Rs 210 but target for the day is Rs 188 and I must caution as days go by less and less pharma stocks will participate. So now its not an across the board kind of kind of a run but other stocks which didn't participate are now getting in.”


At 11:26 hrs the share was quoting at Rs 184.25, up Rs 6.40, or 3.60%. Yesterday the share closed up 8.45% or Rs 13.85 at Rs 177.85. Market capitalisation stands at Rs 266.58 crore.


The company touched its 52 week high Rs 188.70 and 52 week low Rs 56.10 on 25 Mar, 2010 and 25 Mar, 2009, respectively. Currently, it is trading -2.36% below its 52-week high and 228.43% above its 52-week low.


The company's trailing 12-month (TTM) EPS was at Rs 46.21 per share. The stock's price-to-earnings (P/E) ratio was 3.99. The latest book value of the company is Rs 159.04 per share. At current value, the price-to-book value of the company was 1.16. The dividend yield of the company was 0.65%.


Set email alert for

LinkedIn bans prostitutes and escorts from its network
Advani, Swaraj can't wash their hands of  BJP's Karnataka defeat "Advani, Swaraj can't wash their hands of BJP's Karnataka defeat"

From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'

The latest earning numbers FIRST on CNBC-TV18
News Videos

May 18 2013, 17:26

No asset class is risk-free: Axis Cap`s Nandan Chakraborty

- in MARKET OUTLOOK

May 17 2013, 12:39

F&O cues: Nifty to hover in 5800-6200, says Amit Trivedi

- in MARKET OUTLOOK